Catalyst Wire Dossier Catalyst Wire Dossier

Amlodipine besylate 2.5 mg

amlodipine besylate · Oxford Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Amlodipine besylate 2.5 mg, covering 2010-04-07 to 2018-04-02. Get the full timeline:

Most recent: FDA Approved: AMLODIPINE BESYLATE 2.5 MG — Supplemental Application (Oxford Pharmaceuticals, LLC)

See pricing